Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Capital Expenditures: 2020-2023

Historic Capital Expenditures for Cullinan Therapeutics (CGEM) over the last 1 years, with Jun 2023 value amounting to $49,000.

  • Cullinan Therapeutics' Capital Expenditures was N/A to $49,000 in Q2 2023 from the same period last year, while for Jun 2023 it was $1.3 million, marking a year-over-year change of. This contributed to the annual value of $208,000 for FY2023, which is 81.64% down from last year.
  • Per Cullinan Therapeutics' latest filing, its Capital Expenditures stood at $49,000 for Q2 2023, which was down 69.18% from $159,000 recorded in Q1 2023.
  • Cullinan Therapeutics' 5-year Capital Expenditures high stood at $882,000 for Q4 2022, and its period low was -$1,000 during Q4 2020.
  • In the last 2 years, Cullinan Therapeutics' Capital Expenditures had a median value of $205,000 in 2022 and averaged $335,250.